LILLY IN ZYPRESPACE: ZYPREXA EXCITES 30% MARKET JUMP IN 1996; GLAXO ZANTAC, ZOVIRAX PATENT EXPIRATIONS WILL TEST BULL's STRENGTH; BRISTOL WEATHERS CAPOTEN
Executive Summary
Lilly's launch of the antipsychotic Zyprexa is impressing Wall Street and helping to convince investors that there is an active life for the company as it moves into Prozac maturity